SRZNW Insider Trading - Surrozen, Inc.

Total de Insiders

Pontuação de Sentimento de Insider

A Pontuação de Sentimento de Insider encontra as empresas que estão sendo compradas por insiders corporativos.

É o resultado de um modelo quantitativo sofisticado e multifatorial que identifica empresas com os mais altos níveis de acumulação por insiders. O modelo de pontuação usa uma combinação do número líquido de insiders comprando nos últimos 90 dias, o total de ações compradas como um percentual do float, e o total de ações possuídas por insiders. A escala varia de 0 a 100, com números mais altos indicando um maior nível de acumulação em relação aos seus pares, e 50 sendo a média.

Frequência de Atualização: Diariamente

Veja as Principais Escolhas dos Insiders, que fornece uma lista de empresas com a maior acumulação de insiders.

Veja as Ações de Maior Classificação

Pontuação de Sentimento dos Oficiais

A Pontuação de Sentimento de Officer encontra empresas que estão sendo compradas por Oficiais Corporativos.

Por definição, Oficiais Corporativos são Insiders Corporativos, mas, ao contrário de alguns outros Insiders (Acionistas de 10% e Membros do Conselho), os Oficiais trabalham para a empresa diariamente, e eles usam seu próprio dinheiro ao negociar. (Acionistas de 10% e Membros do Conselho muitas vezes são gestores de fundos que gerenciam o dinheiro de outras pessoas.) Como tal, as negociações de insiders feitas por Oficiais são muito mais significativas e devem ser tratadas apropriadamente.

Como a Pontuação de Sentimento dos Insiders, a Pontuação de Sentimento de Officer é o resultado de um modelo quantitativo sofisticado e multifatorial que identifica empresas com os mais altos níveis de acumulação por parte dos oficiais.

Frequência de Atualização: Diariamente

Veja as Principais Escolhas dos Insiders, que fornece uma lista de empresas com maior sentimento dos insiders.

Veja as Ações de Maior Classificação

Principais Métricas de Insider

Este cartão mostra como a empresa se classifica em várias métricas internas. O percentil mostra como esta empresa se compara a outras empresas nos mercados dos EUA. Classificações mais altas são indicativas de situações melhores.

Por exemplo, geralmente aceita-se que a compra interna é um indicador positivo, portanto, empresas com mais compras internas teriam classificações mais altas do que empresas com menos compras internas (ou até mesmo venda interna).

Número Líquido de Insiders Comprando (Classificação)

N/A

Número Líquido de Insiders Comprando é o número total de insiders comprando menos o número total de insiders vendendo nos últimos 90 dias. O percentil é mostrado aqui (varia de 0 a 100%).

Percentual do Float Comprado por Insiders (Classificação)

N/A

Percentual do Float Comprado por Insiders é o número total de ações compradas por insiders menos o número total de ações vendidas por insiders nos últimos 90 dias, dividido pelo total flutuante e multiplicado por 100.

Gráfico de Negociação de Insider

Surrozen, Inc. - Equity Warrant negociações de insiders são mostradas no seguinte gráfico. Insiders são oficiais, diretores ou investidores significativos em uma empresa. Em geral, é geralmente ilegal para insiders realizarem negociações em suas empresas com base em informações materiais, não públicas. Isso não significa que seja ilegal para eles fazerem quaisquer negociações em suas próprias empresas. No entanto, eles devem relatar todas as negociações à SEC através de um Formulário 4.

Roster de Insider e Métricas de Lucratividade

Esta tabela mostra a lista de insiders conhecidos, e é gerada automaticamente a partir de arquivamentos divulgados à SEC. Além dos nomes, título mais recente, e designação de diretor, oficial ou proprietário de 10%, fornecemos as últimas participações divulgadas. Adicionalmente, quando possível fornecemos o desempenho comercial histórico do insider. O desempenho comercial histórico é uma média ponderada do desempenho de transações reais de compra no mercado aberto feitas pelo insider. Para mais informações sobre como isso é calculado, assista este webinar no YouTube.

See our leaderboard of most profitable insider traders.

Insider	Ações Possuídas	Ajuste de Divisão
Mitchell J Md Blutt 10% Owner - [10%]	0	0
Anna Berkenblit Director - [D]	35,129	2,342
Christopher Y Chai Director - [D]	35,129	2,342
Column Group Iii Gp, Lp 10% Owner - [10%]	1,361,485	1,361,485
Column Group Iii, Lp 10% Owner - [10%]	4,904,884	1,361,485
Column Group Iii-a, Lp 10% Owner - [10%]	4,904,884	1,361,485
Consonance Capital Management LP Director, 10% Owner - [D] [10%]	450,828	0
Consonance Capital Opportunity Fund Management LP Director - [D]	0	128,900
Consonance Capman GP, LLC Director - [D]	450,828	0

Insider	Ações Possuídas	Ajuste de Divisão
Consonance Life Sciences 10% Owner - [10%]	1,885,000	0
Mary Haak-Frendscho Director - [D]	35,129	2,342
Christopher Haqq -	30,000	2,000
Joshua Cory House	0
Jennifer Jarrett -	30,000	2,000
Tim Kutzkey Director, 10% Owner - [D] [10%]	1,361,485	1,361,485
Yang Li Exec. Vice President, Research - [O]	17,216	17,216
Shao-Lee Lin Director - [D]	35,129	2,342
Kevin Harold Livingston 10% Owner - [10%]	1,885,000	0

Insider	Ações Possuídas	Ajuste de Divisão
Craig C Parker Chief Executive Officer, Director - [D] [O]	16,553	16,553
Mace Rothenberg Director - [D]	35,129	2,342
Donald J Santel -	30,000	2,000
Benny Soffer 10% Owner - [10%]	1,885,000	0
Gad Soffer	0
TCG Crossover GP II, LLC 10% Owner - [10%]	736,547	736,547
Geertrui Vanhove Chief Medical Officer - [O]	32,412	2,161
David J Woodhouse Director - [D]	35,129	2,342
Charles O Williams Chief Operating Officer - [O]	16,571	16,571
Wen-Chen Yeh Chief Scientific Officer - [O]	27,216	1,814

Report errors via our new Insider Auditing Tool

Acompanhar Históricos de Compras de Insiders - Análise de Lucro a Curto Prazo

Nesta seção, analisamos a lucratividade de cada compra de insider não planejada, feita no mercado aberto em SRZNW / Surrozen, Inc. - Equity Warrant. Esta análise ajuda a entender se o insider gera consistentemente retornos anormais, e vale a pena ser seguido. Esta análise é para um ano após cada negociação, e os resultados são teóricos .

A tabela a seguir mostra as compras mais recentes no mercado aberto que não fizeram parte de um plano de negociação automática.

Data de Negociação	Insider	Reported Shares	Preço Reportado	Ações Ajustadas	Preço Ajustado	Base de Custo	Dias até Máx	Preço em Máx	Lucro Máximo ($)	Retorno Máximo (%)
2026-03-24	TCG Crossover GP II, LLC	53,329	24.6931	53,329	24.6931	1,316,858	43	34.1300	503,261	38.22
2026-03-24	TCG Crossover GP II, LLC	53,329	24.6931	53,329	24.6931	1,316,858
2026-03-23	TCG Crossover GP II, LLC	7,611	24.8999	7,611	24.8999	189,513
2026-03-23	TCG Crossover GP II, LLC	7,612	24.8999	7,612	24.8999	189,538
2026-03-16	TCG Crossover GP II, LLC	595	24.9857	595	24.9857	14,866
2026-03-16	TCG Crossover GP II, LLC	595	24.9857	595	24.9857	14,866
2026-03-13	TCG Crossover GP II, LLC	17,716	24.8769	17,716	24.8769	440,719
2026-03-13	TCG Crossover GP II, LLC	17,717	24.8769	17,717	24.8769	440,744
2026-03-12	TCG Crossover GP II, LLC	6,187	24.9851	6,187	24.9851	154,583

Preço Ajustado é o preço ajustado pelo desdobramento. Ações Ajustadas são as ações ajustadas pelo desdobramento.

SRZNW / Surrozen, Inc. - Equity Warrant Insider Trades

Acompanhar Históricos de Vendas de Insiders - Análise de Perda a Curto Prazo

Nesta seção, analisamos a evitação de perda de curto prazo de cada venda de insider não planejada, feita no mercado aberto em SRZNW / Surrozen, Inc. - Equity Warrant. Um padrão consistente de evitação de perdas pode sugerir que transações de venda futuras possam prever quedas no preço. Esta análise é para um ano após cada negociação, e os resultados são teóricos .

A tabela a seguir mostra as vendas mais recentes no mercado aberto que não fizeram parte de um plano de negociação automática.

Data de Negociação	Insider	Reported Shares	Preço Reportado	Ações Ajustadas	Preço Ajustado	Base de Custo	Dias até Mín	Preço em Mín	Máxima Perda Evitada ($)	Máxima Perda Evitada (%)
2026-05-04	Williams Charles O	2,036	33.3328	2,036	33.3328	67,866	29	23.1450	-20,742	-30.56
2026-05-04	Parker Craig C	4,524	33.3328	4,524	33.3328	150,798
2026-05-04	Li Yang	1,584	33.3328	1,584	33.3328	52,799
2026-01-05	Li Yang	1,118	19.8652	1,118	19.8652	22,209
2026-01-05	Williams Charles O	1,566	19.8652	1,566	19.8652	31,109
2025-01-03	Williams Charles O	1,181	17.3700	1,181	17.3700	20,514
2025-01-03	Li Yang	843	17.3700	843	17.3700	14,643
2022-12-14	BLUTT MITCHELL J MD	1,748,750		116,583
2022-12-14	BLUTT MITCHELL J MD	1,297,922		86,528

Preço Ajustado é o preço ajustado pelo desdobramento. Ações Ajustadas são as ações ajustadas pelo desdobramento.

Histórico de Transações

Clique no ícone de link para ver o histórico completo de transações. As transações relatadas como parte de um plano de negociação automática 10b5-1 terão um X na coluna marcada como 10b-5.

Arquivo Data	Data da Operação	Formulário	Insider	Ticker	Título de Segurança	Código	Direto	Preço de Exercício Preço Unitário	Preço por Unidade	Unidades Alteradas	Valor Alterado (1K)	Opções Restantes	Ações Restantes
2026-05-05	2026-05-04	4	Li Yang	SRZN	Common Stock	S - Sale	D		33.3328	-1,584	-53		17,216
2026-05-05	2026-05-01	4	Li Yang	SRZN	Common Stock	M - Exercise	D			4,375			18,800
2026-05-05	2026-05-04	4	Williams Charles O	SRZN	Common Stock	S - Sale	D		33.3328	-2,036	-68		16,571
2026-05-05	2026-05-01	4	Williams Charles O	SRZN	Common Stock	M - Exercise	D			5,625			18,607
2026-05-05	2026-05-04	4	Parker Craig C	SRZN	Common Stock	S - Sale	D		33.3328	-4,524	-151		16,553
2026-05-05	2026-05-01	4	Parker Craig C	SRZN	Common Stock	M - Exercise	D			12,500			21,077
2026-04-01	2026-03-31	4	Li Yang	SRZN	Common Stock	G - Gift	D			-1,666			14,425
2026-03-25	2026-03-24	4	TCG Crossover GP II, LLC	SRZN	Common Stock	P - Purchase	I		24.6931	53,329	1,317		736,547
2026-03-25	2026-03-24	4	TCG Crossover GP II, LLC	SRZN	Common Stock	P - Purchase	I		24.6931	53,329	1,317		736,554
2026-03-25	2026-03-23	4	TCG Crossover GP II, LLC	SRZN	Common Stock	P - Purchase	I		24.8999	7,611	190		683,218
2026-03-25	2026-03-23	4	TCG Crossover GP II, LLC	SRZN	Common Stock	P - Purchase	I		24.8999	7,612	190		683,225
2026-03-16	2026-03-16	4	TCG Crossover GP II, LLC	SRZN	Common Stock	P - Purchase	I		24.9857	595	15		675,610
2026-03-16	2026-03-16	4	TCG Crossover GP II, LLC	SRZN	Common Stock	P - Purchase	I		24.9857	595	15		675,613
2026-03-16	2026-03-13	4	TCG Crossover GP II, LLC	SRZN	Common Stock	P - Purchase	I		24.8769	17,716	441		675,015
2026-03-16	2026-03-13	4	TCG Crossover GP II, LLC	SRZN	Common Stock	P - Purchase	I		24.8769	17,717	441		675,018
2026-03-16	2026-03-12	4	TCG Crossover GP II, LLC	SRZN	Common Stock	P - Purchase	I		24.9851	6,187	155		657,299
2026-03-16	2026-03-12	4	TCG Crossover GP II, LLC	SRZN	Common Stock	P - Purchase	I		24.9851	6,187	155		657,301
2026-02-13	2026-02-12	4	TCG Crossover GP II, LLC	SRZN	Common Stock	P - Purchase	I		23.8625	546	13		651,112
2026-02-13	2026-02-12	4	TCG Crossover GP II, LLC	SRZN	Common Stock	P - Purchase	I		23.8625	547	13		651,114
2026-02-13	2026-02-11	4	TCG Crossover GP II, LLC	SRZN	Common Stock	P - Purchase	I		23.5750	8,881	209		650,563
2026-02-13	2026-02-11	4	TCG Crossover GP II, LLC	SRZN	Common Stock	P - Purchase	I		23.5750	8,882	209		650,567
2026-02-03	2026-02-03	4	TCG Crossover GP II, LLC	SRZN	Common Stock	P - Purchase	I		21.9400	2,177	48		641,682
2026-02-03	2026-02-03	4	TCG Crossover GP II, LLC	SRZN	Common Stock	P - Purchase	I		21.9400	2,178	48		641,685
2026-02-03	2026-02-02	4	TCG Crossover GP II, LLC	SRZN	Common Stock	P - Purchase	I		21.3800	365	8		639,505
2026-02-03	2026-02-02	4	TCG Crossover GP II, LLC	SRZN	Common Stock	P - Purchase	I		21.3800	366	8		639,507
2026-02-03	2026-01-30	4	TCG Crossover GP II, LLC	SRZN	Common Stock	P - Purchase	I		21.3900	2,135	46		639,140
2026-02-03	2026-01-30	4	TCG Crossover GP II, LLC	SRZN	Common Stock	P - Purchase	I		21.3900	2,136	46		639,141
2026-01-28		3	TCG Crossover GP II, LLC	SRZN	Common Stock		I						637,005
2026-01-28		3	TCG Crossover GP II, LLC	SRZN	Common Stock		I						637,005
2026-01-20	2026-01-20	4	COLUMN GROUP III GP, LP By The Column Group III-A, LP	SRZN	Common Stock	P - Purchase	I		19.5999	9,568	188		1,016,658
2026-01-20	2026-01-20	4	COLUMN GROUP III GP, LP By The Column Group III, LP	SRZN	Common Stock	P - Purchase	I		19.5999	8,484	166		900,292
2026-01-20	2026-01-16	4	COLUMN GROUP III GP, LP By The Column Group III-A, LP	SRZN	Common Stock	P - Purchase	I		20.0000	1,358	27		1,007,090
2026-01-20	2026-01-16	4	COLUMN GROUP III GP, LP By The Column Group III, LP	SRZN	Common Stock	P - Purchase	I		20.0000	1,204	24		891,808
2026-01-20	2026-01-15	4	COLUMN GROUP III GP, LP By The Column Group III-A, LP	SRZN	Common Stock	P - Purchase	I		19.8890	6,303	125		1,005,732
2026-01-20	2026-01-15	4	COLUMN GROUP III GP, LP By The Column Group III, LP	SRZN	Common Stock	P - Purchase	I		19.8890	5,590	111		890,604
2026-01-20	2026-01-20	4	Kutzkey Tim By The Column Group III-A, LP	SRZN	Common Stock	P - Purchase	I		19.5999	9,568	188		1,016,658
2026-01-20	2026-01-20	4	Kutzkey Tim By The Column Group III, LP	SRZN	Common Stock	P - Purchase	I		19.5999	8,484	166		900,292
2026-01-20	2026-01-16	4	Kutzkey Tim By The Column Group III-A, LP	SRZN	Common Stock	P - Purchase	I		20.0000	1,358	27		1,007,090
2026-01-20	2026-01-16	4	Kutzkey Tim By The Column Group III, LP	SRZN	Common Stock	P - Purchase	I		20.0000	1,204	24		891,808
2026-01-20	2026-01-15	4	Kutzkey Tim By The Column Group III-A, LP	SRZN	Common Stock	P - Purchase	I		19.8890	6,303	125		1,005,732
2026-01-20	2026-01-15	4	Kutzkey Tim By The Column Group III, LP	SRZN	Common Stock	P - Purchase	I		19.8890	5,590	111		890,604
2026-01-15	2026-01-14	4	COLUMN GROUP III GP, LP By The Column Group III-A, LP	SRZN	Common Stock	P - Purchase	I		19.9883	2,927	59		999,429
2026-01-15	2026-01-14	4	COLUMN GROUP III GP, LP By The Column Group III, LP	SRZN	Common Stock	P - Purchase	I		19.9883	2,596	52		885,014
2026-01-15	2026-01-13	4	COLUMN GROUP III GP, LP By The Column Group III-A, LP	SRZN	Common Stock	P - Purchase	I		19.8041	6,609	131		996,502
2026-01-15	2026-01-13	4	COLUMN GROUP III GP, LP By The Column Group III, LP	SRZN	Common Stock	P - Purchase	I		19.8041	5,861	116		882,418
2026-01-15	2026-01-14	4	Kutzkey Tim By The Column Group III-A, LP	SRZN	Common Stock	P - Purchase	I		19.9883	2,927	59		999,429
2026-01-15	2026-01-14	4	Kutzkey Tim By The Column Group III, LP	SRZN	Common Stock	P - Purchase	I		19.9883	2,596	52		885,014
2026-01-15	2026-01-13	4	Kutzkey Tim By The Column Group III-A, LP	SRZN	Common Stock	P - Purchase	I		19.8041	6,609	131		996,502
2026-01-15	2026-01-13	4	Kutzkey Tim By The Column Group III, LP	SRZN	Common Stock	P - Purchase	I		19.8041	5,861	116		882,418
2026-01-08	2026-01-06	4	COLUMN GROUP III GP, LP By The Column Group III-A, LP	SRZN	Common Stock	P - Purchase	I		19.8872	8,003	159		989,893
2026-01-08	2026-01-06	4	COLUMN GROUP III GP, LP By The Column Group III, LP	SRZN	Common Stock	P - Purchase	I		19.8872	7,097	141		876,557
2026-01-08	2026-01-06	4	Kutzkey Tim By The Column Group III-A, LP	SRZN	Common Stock	P - Purchase	I		19.8872	8,003	159		989,893
2026-01-08	2026-01-06	4	Kutzkey Tim By The Column Group III, LP	SRZN	Common Stock	P - Purchase	I		19.8872	7,097	141		876,557
2026-01-06	2026-01-05	4	Li Yang	SRZN	Common Stock	S - Sale	D		19.8652	-1,118	-22		16,091
2026-01-06	2026-01-02	4	Li Yang	SRZN	Common Stock	M - Exercise	D			2,500			17,209
2026-01-06	2026-01-05	4	Williams Charles O	SRZN	Common Stock	S - Sale	D		19.8652	-1,566	-31		12,982
2026-01-06	2026-01-02	4	Williams Charles O	SRZN	Common Stock	M - Exercise	D			3,500			14,548
2025-12-16	2025-12-15	4	Li Yang	SRZN	Common Stock	A - Award	D		8.1100	1,666	14		14,709
2025-12-16	2025-12-15	4	Williams Charles O	SRZN	Common Stock	A - Award	D		8.1100	1,666	14		11,048
2025-12-16	2025-12-15	4	Parker Craig C	SRZN	Common Stock	A - Award	D		8.1100	1,553	13		8,577
2025-12-08	2025-12-05	4	Kutzkey Tim By The Column Group III-A, LP	SRZN	Common Stock	P - Purchase	I		19.5409	16,381	320		981,890
2025-12-08	2025-12-05	4	Kutzkey Tim By The Column Group III, LP	SRZN	Common Stock	P - Purchase	I		19.5409	14,503	283		869,460
2025-12-08	2025-12-04	4	Kutzkey Tim By The Column Group III-A, LP	SRZN	Common Stock	P - Purchase	I		17.3470	2,791	48		965,509
2025-12-08	2025-12-04	4	Kutzkey Tim By The Column Group III, LP	SRZN	Common Stock	P - Purchase	I		17.3470	2,475	43		854,957
2025-12-08	2025-12-05	4	COLUMN GROUP III GP, LP By The Column Group III-A, LP	SRZN	Common Stock	P - Purchase	I		19.5409	16,381	320		981,890
2025-12-08	2025-12-05	4	COLUMN GROUP III GP, LP By The Column Group III, LP	SRZN	Common Stock	P - Purchase	I		19.5409	14,503	283		869,460
2025-12-08	2025-12-04	4	COLUMN GROUP III GP, LP By The Column Group III-A, LP	SRZN	Common Stock	P - Purchase	I		17.3470	2,791	48		965,509
2025-12-08	2025-12-04	4	COLUMN GROUP III GP, LP By The Column Group III, LP	SRZN	Common Stock	P - Purchase	I		17.3470	2,475	43		854,957
2025-12-02	2025-11-13	4	Kutzkey Tim By The Column Group III-A, LP	SRZN	Common Stock	P - Purchase	I		12.6500	167,307	2,116		962,718
2025-12-02	2025-11-13	4	Kutzkey Tim By The Column Group III, LP	SRZN	Common Stock	P - Purchase	I		12.6500	148,150	1,874		852,482
2025-11-17	2025-11-13	4	COLUMN GROUP III GP, LP By The Column Group III-A, LP	SRZN	Common Stock	P - Purchase	I		12.6500	167,307	2,116		962,718
2025-11-17	2025-11-13	4	COLUMN GROUP III GP, LP By The Column Group III, LP	SRZN	Common Stock	P - Purchase	I		12.6500	148,150	1,874		852,482
2025-06-16	2025-06-13	4	Li Yang	SRZN	Common Stock	A - Award	D		8.0600	400	3		13,043
2025-06-16	2025-06-13	4	Williams Charles O	SRZN	Common Stock	A - Award	D		8.0600	400	3		9,382
2025-06-16	2025-06-13	4	Parker Craig C	SRZN	Common Stock	A - Award	D		8.0600	400	3		7,024
2025-03-28		3	Kutzkey Tim By The Column Group III-A, LP	SRZN	Common Stock		I						795,411
2025-03-28		3	Kutzkey Tim By The Column Group Opportunity III, LP	SRZN	Common Stock		I						344,827
2025-03-28		3	Kutzkey Tim By The Column Group III, LP	SRZN	Common Stock		I						704,332
2025-03-28	2025-03-26	4	COLUMN GROUP III GP, LP By The Column Group Opportunity III, LP	SRZN	Common Stock	P - Purchase	I		11.6000	344,827	4,000		344,827
2025-03-28	2025-03-26	4	COLUMN GROUP III GP, LP By The Column Group III-A, LP	SRZN	Common Stock	P - Purchase	I		11.6000	365,769	4,243		795,411
2025-03-28	2025-03-26	4	COLUMN GROUP III GP, LP By The Column Group III, LP	SRZN	Common Stock	P - Purchase	I		11.6000	323,886	3,757		704,332
2025-01-06	2025-01-03	4	Li Yang	SRZN	Common Stock	S - Sale	D		17.3700	-843	-15		13,345
2025-01-06	2025-01-02	4	Li Yang	SRZN	Common Stock	M - Exercise	D			2,500			14,188
2025-01-06	2025-01-03	4	Williams Charles O	SRZN	Common Stock	S - Sale	D		17.3700	-1,181	-21		8,982
2025-01-06	2025-01-02	4	Williams Charles O	SRZN	Common Stock	M - Exercise	D			3,500			10,163
2024-06-18	2024-06-14	4	Li Yang	SRZN	Common Stock	A - Award	D		5.6700	400	2		10,888
2024-06-18	2024-06-14	4	Williams Charles O	SRZN	Common Stock	A - Award	D		5.6700	400	2		5,863
2024-06-18	2024-06-14	4	Parker Craig C	SRZN	Common Stock	A - Award	D		5.6700	400	2		5,824
2024-04-17	2024-04-04	4/A	COLUMN GROUP III GP, LP By The Column Group III-A, LP	SRZN	Common Stock	P - Purchase	I		15.5000	102,651	1,591		326,992
2024-04-17	2024-04-04	4/A	COLUMN GROUP III GP, LP By The Column Group III, LP	SRZN	Common Stock	P - Purchase	I		15.5000	90,897	1,409		289,549
2024-04-17	2024-04-04	4/A	Kutzkey Tim By The Column Group III-A, LP	SRZN	Common Stock	P - Purchase	I		15.5000	102,651	1,591		326,992
2024-04-17	2024-04-04	4/A	Kutzkey Tim By The Column Group III, LP	SRZN	Common Stock	P - Purchase	I		15.5000	90,897	1,409		289,549
2024-04-08	2024-04-04	4	Williams Charles O	SRZN	Common Stock	P - Purchase	D			1,474			1,474
2024-04-08	2024-04-04	4	Parker Craig C	SRZN	Common Stock	P - Purchase	D			1,474			1,474
2024-04-08	2024-04-04	4	COLUMN GROUP III GP, LP By The Column Group III-A, LP	SRZN	Common Stock	P - Purchase	I		15.5000	102,651	1,591		332,885
2024-04-08	2024-04-04	4	COLUMN GROUP III GP, LP By The Column Group III, LP	SRZN	Common Stock	P - Purchase	I		15.5000	90,897	1,409		294,767
2024-04-08	2024-04-04	4	Kutzkey Tim By The Column Group III-A, LP	SRZN	Common Stock	P - Purchase	I		15.5000	102,651	1,591		332,885
2024-04-08	2024-04-04	4	Kutzkey Tim By The Column Group III, LP	SRZN	Common Stock	P - Purchase	I		15.5000	90,897	1,409		294,767
2023-12-18	2023-12-15	4	Williams Charles O	SRZN	Common Stock	A - Award	D		5.6700	2,085	12		2,085
2023-12-18	2023-12-15	4	Li Yang	SRZN	Common Stock	A - Award	D		5.6700	2,085	12		2,085
2023-12-18	2023-12-15	4	Parker Craig C	SRZN	Common Stock	A - Award	D		5.6700	2,046	12		2,046
2023-08-23		3	Li Yang	SRZN	Common Stock		I						10,538
2023-08-23		3	Li Yang	SRZN	Common Stock		D						121,524
2023-06-20	2023-06-15	4	Yeh Wen-Chen	SRZN	Common Stock	A - Award	D		0.3800	17,638	7		27,216
2023-06-20	2023-06-15	4	Parker Craig C	SRZN	Common Stock	A - Award	D		0.3800	25,000	10		34,578
2023-06-20	2023-06-15	4	Williams Charles O	SRZN	Common Stock	A - Award	D		0.3800	25,000	10		34,578
2022-12-19	2022-12-15	4	Yeh Wen-Chen	SRZN	Common Stock	A - Award	D		0.4100	9,578	4		229,138
2022-12-19	2022-12-15	4	Parker Craig C	SRZN	Common Stock	A - Award	D		0.4100	9,578	4		9,578
2022-12-19	2022-12-15	4	Vanhove Geertrui	SRZN	Common Stock	A - Award	D		0.4100	9,578	4		32,412
2022-12-19	2022-12-15	4	Williams Charles O	SRZN	Common Stock	A - Award	D		0.4100	9,578	4		9,578
2022-12-15	2022-12-14	4	BLUTT MITCHELL J MD By Consonance Life Sciences, LLC	SRZN	Common Stock	S - Sale	I			-1,885,000			0
2022-12-15	2022-12-14	4	BLUTT MITCHELL J MD By Managed Account	SRZN	Common Stock	S - Sale	I			-450,827			0
2022-12-15	2022-12-14	4	BLUTT MITCHELL J MD By Consonance Capital Opportunity Master Fund, LP	SRZN	Common Stock	S - Sale	I			-1,297,922			0
2022-12-15	2022-12-14	4	BLUTT MITCHELL J MD By Consonance Capital Master Account LP	SRZN	Common Stock	S - Sale	I			-1,748,750			0
2022-03-03	2022-03-01	4	Yeh Wen-Chen	SRZN	Option (right to buy)	A - Award	D	3.11		125,000		125,000
2022-03-03	2022-03-01	4	Parker Craig C	SRZN	Stock Option (right to buy)	A - Award	D	3.11		370,000		370,000
2022-03-03	2022-03-01	4	Williams Charles O	SRZN	Option (right to buy)	A - Award	D	3.11		125,000		125,000
2022-03-03	2022-03-01	4	Vanhove Geertrui	SRZN	Option Grant (right to buy)	A - Award	D	3.11	3.1100	125,000	389	125,000
2021-08-16		3	COLUMN GROUP III, LP By The Column Group III, LP	SRZN	Common Stock		I						4,343,245
2021-08-16		3	COLUMN GROUP III, LP By The Column Group III-A, LP	SRZN	Common Stock		I						4,904,884
2021-08-16		3	Kutzkey Tim By The Column Group III, LP	SRZN	Common Stock		I						4,343,245
2021-08-16		3	Kutzkey Tim By The Column Group III-A, LP	SRZN	Common Stock		I						4,904,884
2021-08-16	2021-08-12	4	Parker Craig C	SRZN	Stock Option (right to buy)	A - Award	D	10.25		183,335		183,335
2021-08-16	2021-08-12	4	Vanhove Geertrui	SRZN	Employee Stock Option (right to buy)	A - Award	D	10.25		36,647		36,647
2021-08-16		3	Vanhove Geertrui	SRZN	Common Stock		D						22,834
2021-08-16	2021-08-12	4	Williams Charles O	SRZN	Employee Stock Option (right to buy)	A - Award	D	10.25		14,597		14,597
2021-08-16		3	WOODHOUSE DAVID J	SRZN	Common Stock		D						35,129
2021-08-16		3	Rothenberg Mace	SRZN	Common Stock		D						35,129
2021-08-16		3	Haak-Frendscho Mary	SRZN	Common Stock		D						35,129
2021-08-16		3	Berkenblit Anna	SRZN	Common Stock		D						35,129
2021-08-16		3	Lin Shao-Lee	SRZN	Common Stock		D						35,129
2021-08-16		3	Yeh Wen-Chen	SRZN	Common Stock		D						219,560
2021-08-16		3	CHAI CHRISTOPHER Y	SRZN	Common Stock		D						35,129
2021-08-13	2021-08-11	4	Consonance Life Sciences	SRZN	Warrants	A - Award	I	11.50		-144,667		144,667
2021-08-13	2021-08-11	4	Consonance Life Sciences	SRZN	Warrants	D - Sale to Issuer	I	11.50		-144,667		0
2021-08-13	2021-08-11	4	Consonance Life Sciences	SRZN	Common Stock	A - Award	I			1,451,000			1,885,000
2021-08-13	2021-08-11	4	Consonance Life Sciences	SRZN	Common Stock	A - Award	I			434,000			434,000
2021-08-13	2021-08-11	4	Consonance Life Sciences	SRZN	Class B Ordinary Shares	D - Sale to Issuer	I			-1,451,000			0
2021-08-13	2021-08-11	4	Consonance Life Sciences	SRZN	Class B Ordinary Shares	J - Other	I			-759,000			1,451,000
2021-08-13	2021-08-11	4	Consonance Life Sciences	SRZN	Class A Ordinary Shares	D - Sale to Issuer	I			-434,000			0
2021-08-13	2021-08-11	4	Jarrett Jennifer	SRZN	Class B Ordinary Shares	D - Sale to Issuer	D			-30,000		0
2021-08-13	2021-08-11	4	Jarrett Jennifer	SRZN	Common Stock	A - Award	D			30,000			30,000
2021-08-13	2021-08-11	4	Santel Donald J	SRZN	Class B Ordinary Shares	D - Sale to Issuer	D			-30,000		0
2021-08-13	2021-08-11	4	Santel Donald J	SRZN	Common Stock	A - Award	D			30,000			30,000
2021-08-13	2021-08-11	4	Soffer Benny	SRZN	Warrants	A - Award	I	11.50		-144,667		144,667
2021-08-13	2021-08-11	4	Soffer Benny	SRZN	Warrants	D - Sale to Issuer	I	11.50		-144,667		0
2021-08-13	2021-08-11	4	Soffer Benny	SRZN	Common Stock	A - Award	I			1,451,000			1,885,000
2021-08-13	2021-08-11	4	Soffer Benny	SRZN	Common Stock	A - Award	I			434,000			434,000
2021-08-13	2021-08-11	4	Soffer Benny	SRZN	Class B Ordinary Shares	D - Sale to Issuer	I			-1,451,000			0
2021-08-13	2021-08-11	4	Soffer Benny	SRZN	Class B Ordinary Shares	J - Other	I			-759,000			1,451,000
2021-08-13	2021-08-11	4	Soffer Benny	SRZN	Class A Ordinary Shares	D - Sale to Issuer	I			-434,000			0
2021-08-13	2021-08-11	4	Haqq Christopher	SRZN	Class B Ordinary Shares	D - Sale to Issuer	D			-30,000		0
2021-08-13	2021-08-11	4	Haqq Christopher	SRZN	Common Stock	A - Award	D			30,000			30,000
2021-08-13	2021-08-11	4	Livingston Kevin Harold	SRZN	Warrants	A - Award	I	11.50		-144,667		144,667
2021-08-13	2021-08-11	4	Livingston Kevin Harold	SRZN	Warrants	D - Sale to Issuer	I	11.50		-144,667		0
2021-08-13	2021-08-11	4	Livingston Kevin Harold	SRZN	Common Stock	A - Award	I			1,451,000			1,885,000
2021-08-13	2021-08-11	4	Livingston Kevin Harold	SRZN	Common Stock	A - Award	I			434,000			434,000
2021-08-13	2021-08-11	4	Livingston Kevin Harold	SRZN	Class B Ordinary Shares	D - Sale to Issuer	I			-1,451,000			0
2021-08-13	2021-08-11	4	Livingston Kevin Harold	SRZN	Class B Ordinary Shares	J - Other	I			-759,000			1,451,000
2021-08-13	2021-08-11	4	Livingston Kevin Harold	SRZN	Class A Ordinary Shares	D - Sale to Issuer	I			-434,000			0
2021-08-13	2021-08-11	4	BLUTT MITCHELL J MD By Managed Account	SRZN	Warrants (right to buy)	A - Award	I	11.50		107,309		150,275
2021-08-13	2021-08-11	4	BLUTT MITCHELL J MD By Consonance Capital Opportunity Master Fund, LP	SRZN	Warrants (right to buy)	A - Award	I	11.50		308,940		432,640
2021-08-13	2021-08-11	4	BLUTT MITCHELL J MD By Consonance Capital Master Account LP	SRZN	Warrants (right to buy)	A - Award	I	11.50		416,250		582,917
2021-08-13	2021-08-11	4	BLUTT MITCHELL J MD By Managed Account	SRZN	Warrants (right to buy)	P - Purchase	I	11.50		42,966		42,966
2021-08-13	2021-08-11	4	BLUTT MITCHELL J MD By Consonance Capital Opportunity Master Fund, LP	SRZN	Warrants (right to buy)	P - Purchase	I	11.50		123,700		123,700
2021-08-13	2021-08-11	4	BLUTT MITCHELL J MD By Consonance Capital Master Account LP	SRZN	Warrants (right to buy)	P - Purchase	I	11.50		166,667		166,667
2021-08-13	2021-08-11	4	BLUTT MITCHELL J MD By Managed Account	SRZN	Common Stock	A - Award	I			321,928			450,828
2021-08-13	2021-08-11	4	BLUTT MITCHELL J MD By Consonance Capital Opportunity Master Fund, LP	SRZN	Common Stock	A - Award	I			926,822			1,297,922
2021-08-13	2021-08-11	4	BLUTT MITCHELL J MD By Consonance Capital Master Account LP	SRZN	Common Stock	A - Award	I			1,248,750			1,748,750
2021-08-13	2021-08-11	4	BLUTT MITCHELL J MD By Managed Account	SRZN	Common Stock	A - Award	I			128,900			128,900
2021-08-13	2021-08-11	4	BLUTT MITCHELL J MD By Managed Account	SRZN	Class A Ordinary Shares	D - Sale to Issuer	I			-128,900			0
2021-08-13	2021-08-11	4	BLUTT MITCHELL J MD By Consonance Capital Opportunity Master Fund, LP	SRZN	Common Stock	A - Award	I			371,100			371,100
2021-08-13	2021-08-11	4	BLUTT MITCHELL J MD By Consonance Capital Opportunity Master Fund, LP	SRZN	Class A Ordinary Shares	D - Sale to Issuer	I			-371,100			0
2021-08-13	2021-08-11	4	BLUTT MITCHELL J MD By Consonance Capital Master Account LP	SRZN	Common Stock	A - Award	I			500,000			500,000
2021-08-13	2021-08-11	4	BLUTT MITCHELL J MD By Consonance Capital Master Account LP	SRZN	Class A Ordinary Shares	D - Sale to Issuer	I			-500,000			0
2021-05-19	2020-11-23	4/A	Consonance Life Sciences	CHFW	Warrant	A - Award	D	11.50		136,667		136,667
2021-05-19	2020-11-23	4/A	Consonance Life Sciences	CHFW	Class A Ordinary Shares	A - Award	D			410,000			410,000
2021-05-19	2020-11-18	4/A	Consonance Life Sciences	CHFW	Class B Ordinary Shares	S - Sale	D		0.0109	-30,000	-0		2,210,000
2021-05-19	2020-11-18	4/A	Consonance Life Sciences	CHFW	Class B Ordinary Shares	S - Sale	D		0.0109	-30,000	-0		2,210,000
2021-05-19	2020-11-18	4/A	Consonance Life Sciences	CHFW	Class B Ordinary Shares	S - Sale	D		0.0109	-30,000	-0		2,240,000
2021-05-19	2020-11-10	4/A	Consonance Life Sciences	CHFW	Class B Ordinary Shares	D - Sale to Issuer	D			-575,000			2,300,000
2021-05-19	2020-10-08	4/A	Consonance Life Sciences	CHFW	Class B Ordinary Shares	D - Sale to Issuer	D			-718,750			2,875,000
2021-05-19	2020-09-04	4/A	Consonance Life Sciences	CHFW	Class B Ordinary Shares	A - Award	D		0.0070	3,593,750	25		3,593,750
2021-05-19	2020-12-01	4/A	Soffer Benny	CHFW	Warrant	A - Award	I	11.50		8,000		144,667
2021-05-19	2020-12-01	4/A	Soffer Benny	CHFW	Class A Ordinary Shares	A - Award	I			24,000			434,000
2021-05-19	2020-11-23	4/A	BLUTT MITCHELL J MD	CHFW	Warrant	A - Award	I	11.50		136,667		136,667
2021-05-19	2020-11-23	4/A	BLUTT MITCHELL J MD	CHFW	Class A Ordinary Shares	A - Award	I			410,000			410,000
2021-05-19	2020-11-18	4/A	BLUTT MITCHELL J MD	CHFW	Class B Ordinary Shares	S - Sale	I		0.0109	-30,000	-0		2,210,000
2021-05-19	2020-11-18	4/A	BLUTT MITCHELL J MD	CHFW	Class B Ordinary Shares	S - Sale	I		0.0109	-30,000	-0		2,210,000
2021-05-19	2020-11-18	4/A	BLUTT MITCHELL J MD	CHFW	Class B Ordinary Shares	S - Sale	I		0.0109	-30,000	-0		2,240,000
2021-05-19	2020-11-10	4/A	BLUTT MITCHELL J MD	CHFW	Class B Ordinary Shares	D - Sale to Issuer	I			-575,000			2,300,000
2021-05-19	2020-10-08	4/A	BLUTT MITCHELL J MD	CHFW	Class B Ordinary Shares	D - Sale to Issuer	I			-718,750			2,875,000
2021-05-19	2020-09-04	4/A	BLUTT MITCHELL J MD	CHFW	Class B Ordinary Shares	A - Award	I		0.0070	3,593,750	25		3,593,750
2021-05-19	2020-11-23	4/A	Soffer Benny	CHFW	Warrant	A - Award	I	11.50		136,667		136,667
2021-05-19	2020-11-23	4/A	Soffer Benny	CHFW	Class A Ordinary Shares	A - Award	I			410,000			410,000
2021-05-19	2020-11-18	4/A	Soffer Benny	CHFW	Class B Ordinary Shares	S - Sale	I		0.0109	-30,000	-0		2,210,000
2021-05-19	2020-11-18	4/A	Soffer Benny	CHFW	Class B Ordinary Shares	S - Sale	I		0.0109	-30,000	-0		2,210,000
2021-05-19	2020-11-18	4/A	Soffer Benny	CHFW	Class B Ordinary Shares	S - Sale	I		0.0109	-30,000	-0		2,240,000
2021-05-19	2020-11-10	4/A	Soffer Benny	CHFW	Class B Ordinary Shares	D - Sale to Issuer	I			-575,000			2,300,000
2021-05-19	2020-10-08	4/A	Soffer Benny	CHFW	Class B Ordinary Shares	D - Sale to Issuer	I			-718,750			2,875,000
2021-05-19	2020-09-04	4/A	Soffer Benny	CHFW	Class B Ordinary Shares	A - Award	I		0.0070	3,593,750	25		3,593,750
2021-05-19	2020-12-01	4/A	Consonance Life Sciences	CHFW	Warrant	A - Award	D	11.50		8,000		144,667
2021-05-19	2020-12-01	4/A	Consonance Life Sciences	CHFW	Class A Ordinary Shares	A - Award	D			24,000			434,000
2021-05-19	2020-12-01	4/A	Livingston Kevin Harold	CHFW	Warrant	A - Award	I	11.50		8,000		144,667
2021-05-19	2020-12-01	4/A	Livingston Kevin Harold	CHFW	Class A Ordinary Shares	A - Award	I			24,000			434,000
2021-05-19	2020-11-23	4/A	Livingston Kevin Harold	CHFW	Warrant	A - Award	I	11.50		136,667		136,667
2021-05-19	2020-11-23	4/A	Livingston Kevin Harold	CHFW	Class A Ordinary Shares	A - Award	I			410,000			410,000
2021-05-19	2020-11-18	4/A	Livingston Kevin Harold	CHFW	Class B Ordinary Shares	S - Sale	I		0.0109	-30,000	-0		2,210,000
2021-05-19	2020-11-18	4/A	Livingston Kevin Harold	CHFW	Class B Ordinary Shares	S - Sale	I		0.0109	-30,000	-0		2,210,000
2021-05-19	2020-11-18	4/A	Livingston Kevin Harold	CHFW	Class B Ordinary Shares	S - Sale	I		0.0109	-30,000	-0		2,240,000
2021-05-19	2020-11-10	4/A	Livingston Kevin Harold	CHFW	Class B Ordinary Shares	D - Sale to Issuer	I			-575,000			2,300,000
2021-05-19	2020-10-08	4/A	Livingston Kevin Harold	CHFW	Class B Ordinary Shares	D - Sale to Issuer	I			-718,750			2,875,000
2021-05-19	2020-09-04	4/A	Livingston Kevin Harold	CHFW	Class B Ordinary Shares	A - Award	I		0.0070	3,593,750	25		3,593,750
2021-05-19	2020-12-01	4/A	BLUTT MITCHELL J MD	CHFW	Warrant	A - Award	I	11.50		8,000		144,667
2021-05-19	2020-12-01	4/A	BLUTT MITCHELL J MD	CHFW	Class A Ordinary Shares	A - Award	I			24,000			434,000
2021-05-19		3/A	BLUTT MITCHELL J MD Consonance Life Sciences, LLC	CHFW	Class B Ordinary Shares		I						2,210,000
2021-05-19		3/A	Soffer Benny Consonance Life Sciences, LLC	CHFW	Class B Ordinary Shares		I						2,210,000
2021-05-19		3/A	Livingston Kevin Harold Consonance Life Sciences, LLC	CHFW	Class B Ordinary Shares		I						2,210,000
2021-05-19		3/A	Consonance Life Sciences	CHFW	Class B Ordinary Shares		D						2,210,000
2020-12-04	2020-11-23	4	BLUTT MITCHELL J MD By Managed Account	CHFW	Class A Ordinary Shares	P - Purchase	I			128,900			128,900
2020-12-04	2020-11-23	4	BLUTT MITCHELL J MD By Consonance Capital Opportunity Master Fund, LP	CHFW	Class A Ordinary Shares	P - Purchase	I			371,100			371,100
2020-12-04	2020-11-23	4	BLUTT MITCHELL J MD By Consonance Capital Master Account, LP	CHFW	Class A Ordinary Shares	P - Purchase	I			500,000			500,000
2020-12-03	2020-12-01	4	Livingston Kevin Harold	CHFW	Warrant	P - Purchase	I	11.50		8,000		144,667
2020-12-03	2020-12-01	4	Livingston Kevin Harold	CHFW	Class A Ordinary Shares	P - Purchase	I			24,000			434,000
2020-12-03	2020-12-01	4	Consonance Life Sciences	CHFW	Warrant	P - Purchase	D	11.50		8,000		144,667
2020-12-03	2020-12-01	4	Consonance Life Sciences	CHFW	Class A Ordinary Shares	P - Purchase	D			24,000			434,000
2020-12-03	2020-12-01	4	Soffer Benny	CHFW	Warrant	P - Purchase	I	11.50		8,000		144,667
2020-12-03	2020-12-01	4	Soffer Benny	CHFW	Class A Ordinary Shares	P - Purchase	I			24,000			434,000
2020-12-03	2020-12-01	4	BLUTT MITCHELL J MD	CHFW	Warrant	P - Purchase	I	11.50		8,000		144,667
2020-12-03	2020-12-01	4	BLUTT MITCHELL J MD	CHFW	Class A Ordinary Shares	P - Purchase	I			24,000			434,000
2020-11-25	2020-11-23	4	Consonance Life Sciences	CHFW	Warrant	P - Purchase	D	11.50		136,667		136,667
2020-11-25	2020-11-23	4	Consonance Life Sciences	CHFW	Class A Ordinary Shares	P - Purchase	D			410,000			410,000
2020-11-25	2020-11-23	4	Soffer Benny	CHFW	Warrant	P - Purchase	I	11.50		136,667		136,667
2020-11-25	2020-11-23	4	Soffer Benny	CHFW	Class A Ordinary Shares	P - Purchase	I			410,000			410,000
2020-11-25	2020-11-23	4	BLUTT MITCHELL J MD	CHFW	Warrant	P - Purchase	I	11.50		136,667		136,667
2020-11-25	2020-11-23	4	BLUTT MITCHELL J MD	CHFW	Class A Ordinary Shares	P - Purchase	I			410,000			410,000
2020-11-25	2020-11-23	4	Livingston Kevin Harold	CHFW	Warrant	P - Purchase	I	11.50		136,667		136,667
2020-11-25	2020-11-23	4	Livingston Kevin Harold	CHFW	Class A Ordinary Shares	P - Purchase	I			410,000			410,000

Compra de mercado aberto ou privada de ativo não-derivativo ou derivativo

Venda de mercado aberto ou privada de ativo não-derivativo ou derivativo

Concessão, premiação, ou outra aquisição de ativos da empresa (como uma opção)

Conversão de derivativo

Venda ou transferência de ativos de volta para a empresa

Pagamento do preço de exercício ou responsabilidade fiscal utilizando parte dos ativos recebidos da empresa

Doação de ativos pelo ou para o insider

Swaps de capital e transações de hedge similares

Exercício ou conversão de ativo derivativo recebido da empresa (como uma opção)

Uma transação voluntariamente reportada no Formulário 4

Outro (acompanhado de uma nota explicativa descrevendo a transação)

SRZNW / Surrozen, Inc. - Equity Warrant - Insider Trading and Ownership Report - SEC Form 3, 4, 5